The Effect of Tear Supplements on Contact Lens Comfort
Primary Purpose
Dry Eye Syndromes, Meibomian Gland Dysfunction
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Systane Balance eye drops
Systane Contacts eye drops
saline
Sponsored by
About this trial
This is an interventional treatment trial for Dry Eye Syndromes
Eligibility Criteria
Inclusion Criteria:
- Patients complaining of contact lens associated discomfort
Exclusion Criteria:
- Patients who do not have contact lens discomfort; patients who have active inflammation or infection of the anterior segment of the eyes.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Placebo Comparator
Arm Label
Lipid based artificial tears
Non-lipid based artificial tears
Saline
Arm Description
Patients use lipid based artificial tears
patients use non-lipid based artificial tears
patients use saline
Outcomes
Primary Outcome Measures
Contact Lens Discomfort Questionnaire
CLDEQ Questionnaire will be used to quantify contact lens discomfort
Secondary Outcome Measures
Fluorescein tear break-up time
Fluorescein will be instilled in the conjunctival sac to assess tear break-up time
Full Information
NCT ID
NCT02956083
First Posted
November 1, 2016
Last Updated
November 2, 2016
Sponsor
University of the Incarnate Word
1. Study Identification
Unique Protocol Identification Number
NCT02956083
Brief Title
The Effect of Tear Supplements on Contact Lens Comfort
Official Title
The Effect of Tear Supplements on Contact Lens Comfort
Study Type
Interventional
2. Study Status
Record Verification Date
November 2016
Overall Recruitment Status
Completed
Study Start Date
July 2014 (undefined)
Primary Completion Date
July 2015 (Actual)
Study Completion Date
July 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of the Incarnate Word
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary goal of this investigation is to determine if lipid based artificial tear supplementation has an impact on contact lens discomfort (CLD).
Detailed Description
Contact lens discomfort (CLD) is the most common cause of discontinuing contact lens wear. Despite years of research and innovations in technology, CLD remains highly prevalent, and thus it is a major concern for patients and practitioners. Studies suggest that meibomian gland dysfunction (MGD) is a cause of CLD. Several lipid-based artificial tears have recently been designed to address dry eye associated with MGD. In this study, the investigators examine if the benefits of lipid based artificial tears extend to improving contact lens comfort. Studies have demonstrated some usefulness of non-lipid based tear supplements in the management of contact lens discomfort. However, the relief was moderate and short-term. To date, no study has examined the impact of lipid based artificial tears on contact lens discomfort. In this study, the investigators will address this gap in knowledge.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dry Eye Syndromes, Meibomian Gland Dysfunction
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Lipid based artificial tears
Arm Type
Active Comparator
Arm Description
Patients use lipid based artificial tears
Arm Title
Non-lipid based artificial tears
Arm Type
Active Comparator
Arm Description
patients use non-lipid based artificial tears
Arm Title
Saline
Arm Type
Placebo Comparator
Arm Description
patients use saline
Intervention Type
Other
Intervention Name(s)
Systane Balance eye drops
Intervention Description
Propylene Glycol 0.6% Over the counter lipid based artificial tears.
Intervention Type
Other
Intervention Name(s)
Systane Contacts eye drops
Intervention Description
Hydroxypropyl methycellulose over the counter non-lipid based artificial tears
Intervention Type
Other
Intervention Name(s)
saline
Intervention Description
Saline - no brand name
Primary Outcome Measure Information:
Title
Contact Lens Discomfort Questionnaire
Description
CLDEQ Questionnaire will be used to quantify contact lens discomfort
Time Frame
1 months
Secondary Outcome Measure Information:
Title
Fluorescein tear break-up time
Description
Fluorescein will be instilled in the conjunctival sac to assess tear break-up time
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients complaining of contact lens associated discomfort
Exclusion Criteria:
Patients who do not have contact lens discomfort; patients who have active inflammation or infection of the anterior segment of the eyes.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Srihari Narayanan, OD, PhD
Organizational Affiliation
University of the Incarnate Word
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Effect of Tear Supplements on Contact Lens Comfort
We'll reach out to this number within 24 hrs